Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices

by | Sep 24, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

Novo Nordisk’s top executive is slated to face a Senate grilling on Tuesday over the high prices of the company’s weight loss drug Wegovy and …

FEATURED